Stroke and thrombolysis in developing countries

Simple item page
dc.contributor.authorPandian, JD
dc.contributor.authorPadma, V
dc.contributor.authorVijaya, P
dc.contributor.authorSylaja, PN
dc.contributor.authorMurthy, JMK
dc.date.accessioned2017-03-10T03:28:38Z
dc.date.available2017-03-10T03:28:38Z
dc.date.issued2007
dc.description.abstractBackground Over the past few decades, the burden of stroke in developing countries has grown to epidemic proportions. Two-thirds of global stroke occurs in low- and middle-income countries. We have found that little information is obtainable concerning the availability of thrombolysis therapy in developing countries. Summary of review The epidemiology of stroke is well investigated in the developed world; however, in the developing world stroke is less well documented. Most of the available stroke data from these countries are hospital-based. Stroke thrombolysis is currently used in few developing countries like Brazil, Argentina, Senegal, Iran, Pakistan, China, Thailand, and India. The two main barriers for implementation of thrombolysis therapy in developing countries are the high cost of tissue plasminogen activator and lack of proper infrastructure. Most of the centers with the infrastructure to deliver thrombolysis for stroke are predominantly private sector, and only available in urban areas. Conclusion Until a more cost-effective thrombolytic agent and the proper infrastructure for widespread use of thrombolysis therapy are available, developing nations should focus on primary and secondary stroke prevention strategies and the establishment of stroke units wherever possible. Such multi-faceted approaches will be more cost-effective for developing countries than the use of thrombolysis.
dc.identifier.citation2 ,1;17-26en_US
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/10464
dc.publisherINTERNATIONAL JOURNAL OF STROKE
dc.subjectCardiovascular System & Cardiology
dc.titleStroke and thrombolysis in developing countries
Files
Collections
Journal Articles